Evidence map›Paper›PMID 32612946›Full record

ArticleFrontiers in oncology2020

CircCSPP1 Functions as a ceRNA to Promote Colorectal Carcinoma Cell EMT and Liver Metastasis by Upregulating COL1A1.

Qingyuan Wang, Linsen Shi, Kui Shi, Bo Yuan, Gang Cao, Chenchen Kong, Jun Fu, Zhongsong Man, Xu Li, Xuanfeng Zhang and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells.Journal of molecular neuroscience : MN · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. HnRNP-L-regulated circCSPP1/miR-520h/Molecular therapy. Nucleic acids · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Qingyuan WangCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Linsen ShiDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Kui ShiCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Bo YuanCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Gang CaoCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Chenchen KongCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Jun FuCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Zhongsong ManCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Xu LiCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Xuanfeng ZhangCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Yifei FengDepartment of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xinchun JiangCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Xinhui ZhangCenter of Hepatobiliary Pancreatic Disease, Xuzhou Central Hospital, Xuzhou, China.
Jun YanCenter of Hepatobiliary Pancreatic Disease, Beijing Tsinghua Changgung Hospital, Beijing, China.
Xinyong WuDepartment of General Surgery, Xuzhou Central Hospital, Xuzhou, China.
Yueming SunDepartment of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xuzhou Central Hospital · CNJiangsu Province Hospital · CNBeijing Tsinghua Chang Gung Hospital · CNNanjing Medical University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aberrant regulation of circular RNAs (circRNAs), ring structures formed by exon or intron backsplicing, has been identified as a novel characteristic of multiple cancers. However, the role of circRNAs in colorectal carcinoma remains to be elucidated. In the present study, we investigated the mRNA level and the promoting effect of circRNA CSPP1 (circCSPP1) in colorectal carcinoma liver metastasis. By bioinformatic analysis of 10 paired samples of colorectal carcinoma and adjacent mucosal tissues, we identified circCSPP1 as a significantly upregulated circRNA in colorectal carcinoma tissues, and its upregulation was correlated with a higher M stage. The gain- and loss-of-function assays revealed that circCSPP1 promotes the migration and invasion of colorectal carcinoma cells

Indexed as

CeRNAcircRNACOL1A1EMTmetastasis

Identifiers

PMID32612946
PMCPMC7308451
OpenAlexW3035389138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.